Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients

Clinical trial NCT00174343 · COMPLETED

Trial details

NCT number: NCT00174343
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2001-11-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.